<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="75565">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01931644</url>
  </required_header>
  <id_info>
    <org_study_id>SAN-BB-01</org_study_id>
    <nct_id>NCT01931644</nct_id>
  </id_info>
  <brief_title>Be the Bridge Between Researchers and a Cure (ALS, Hepatitis B, Melanoma, Alzheimer's Disease, Leukemia, and More)</brief_title>
  <official_title>A Multi-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sanguine Biosciences</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sanguine Biosciences</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      At Sanguine Biosciences, we consider ourselves the bridge between patients like you and
      researchers striving to find the cure. We collect blood and/or tissue samples and in-depth
      profiles for medical researchers. Donate from your home, track your sample, and help
      specialists get the information they need to advance medical research.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will collect blood and other optionally donated tissue samples from people with
      all different types of health conditions, as well as healthy control samples, in order to
      provide biomedical researchers with quality biospecimens that are necessary in translating
      basic science research into clinically relevant information and technology.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">December 2040</completion_date>
  <primary_completion_date type="Anticipated">August 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Cross-Sectional</study_design>
  <primary_outcome>
    <measure>Biospecimen &amp; Clinical Data Collection</measure>
    <time_frame>10 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>To collect enough biospecimens and associated clinical data to allow researchers to come to statistically relevant scientific results</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">20000</enrollment>
  <condition>All Diagnosed Health Conditions</condition>
  <arm_group>
    <arm_group_label>Health Condition</arm_group_label>
    <description>Collect blood and other optional biospecimens from participants with a diagnosed health condition</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Control</arm_group_label>
    <description>Collect blood and other optional biospecimens from participants that have not been diagnosed with a health condition</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood, serum, plasma, PBMC, RNA, DNA, saliva, stool, hair, skin, CSF, synovial fuid,
      tumor tissue, urine
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Diagnosed with a health condition
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All adults 18-100 years old

          -  Able to provide proof of diagnosis

          -  Live in USA

        Exclusion Criteria:

          -  Younger than 18 years old

          -  Receipt of blood products within 30 days of study blood collection

          -  Receipt of investigational drug within 30 days of study blood collection
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carlyn Crisostomo</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sanguine Biosciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Carlyn Crisostomo, MBA</last_name>
    <phone>877-864-3053</phone>
    <email>donors@sanguinebio.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kendra Hughes, MA</last_name>
    <phone>877-864-3053</phone>
    <email>donors@sanguinebio.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sanguine Biosciences</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>91403</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kendra Hughs</last_name>
      <email>study@sanguinebio.com</email>
    </contact>
    <investigator>
      <last_name>Carlyn Crisostomo</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kendra Hughes, MA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 13, 2014</lastchanged_date>
  <firstreceived_date>August 23, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cancer</keyword>
  <keyword>Diabetes</keyword>
  <keyword>Melanoma</keyword>
  <keyword>Hepatitis B</keyword>
  <keyword>Lupus</keyword>
  <keyword>Multiple Sclerosis</keyword>
  <keyword>Asthma</keyword>
  <keyword>Crohn's Disease</keyword>
  <keyword>Ulcerative Colitis</keyword>
  <keyword>Kidney Disease</keyword>
  <keyword>Alzheimer's Disease</keyword>
  <keyword>Parkinson's Disease</keyword>
  <keyword>Huntington's Disease</keyword>
  <keyword>Rheumatoid Arthritis</keyword>
  <keyword>Sjogren's Syndrome</keyword>
  <keyword>Leukemia</keyword>
  <keyword>Lymphoma</keyword>
  <keyword>Myeloma</keyword>
  <keyword>CIDP</keyword>
  <keyword>COPD</keyword>
  <keyword>Idiopathic Thrombocytopenia Purpura</keyword>
  <keyword>Cystic Fibrosis</keyword>
  <keyword>Primary Biliary Cirrhosis</keyword>
  <keyword>ALS</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis B</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
